Hiroko Masamune - Net Worth and Insider Trading

Hiroko Masamune Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hiroko Masamune owns 1 companies in total, including Viking Therapeutics Inc (VKTX) .

Click here to see the complete history of Hiroko Masamune’s form 4 insider trades.

Insider Ownership Summary of Hiroko Masamune

Ticker	Comapny	Transaction Date	Type of Owner
VKTX	Viking Therapeutics Inc	2018-07-01	Chief Development Officer

Hiroko Masamune Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Hiroko Masamune Ownership Network

Ownership Network List of Hiroko Masamune

No Data

Ownership Network Relation of Hiroko Masamune

Hiroko Masamune Owned Company Details

What does Viking Therapeutics Inc do?

Who are the key executives at Viking Therapeutics Inc?

Hiroko Masamune is the Chief Development Officer of Viking Therapeutics Inc. Other key executives at Viking Therapeutics Inc include Chief Financial Officer Greg Zante , director & President & CEO Brian Lian , and Chief Operating Officer Marianna Mancini .

Viking Therapeutics Inc (VKTX) Insider Trades Summary

Over the past 18 months, Hiroko Masamune made no insider transaction in Viking Therapeutics Inc (VKTX). Other recent insider transactions involving Viking Therapeutics Inc (VKTX) include a net sale of 879,938 shares made by Brian Lian , a net sale of 68,786 shares made by J Matthew Singleton , and a net sale of 229,579 shares made by Greg Zante .

In summary, during the past 3 months, insiders sold 543,473 shares of Viking Therapeutics Inc (VKTX) in total and bought 0 shares, with a net sale of 543,473 shares. During the past 18 months, 1,601,754 shares of Viking Therapeutics Inc (VKTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,601,754 shares.

Viking Therapeutics Inc (VKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Viking Therapeutics Inc Insider Transactions

No Available Data

Hiroko Masamune Mailing Address

Above is the net worth, insider trading, and ownership report for Hiroko Masamune. You might contact Hiroko Masamune via mailing address: C/o Viking Therapeutics, Inc., 12340 El Camino Real, Suite 250, San Diego Ca 92130.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.